TRYMEX Drug Patent Profile
✉ Email this page to a colleague
When do Trymex patents expire, and what generic alternatives are available?
Trymex is a drug marketed by Savage Labs and is included in five NDAs.
The generic ingredient in TRYMEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trymex
A generic version of TRYMEX was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for TRYMEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,268 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRYMEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRYMEX
US Patents and Regulatory Information for TRYMEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Savage Labs | TRYMEX | triamcinolone acetonide | CREAM;TOPICAL | 088196-001 | Mar 25, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | TRYMEX | triamcinolone acetonide | OINTMENT;TOPICAL | 088693-001 | Aug 2, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | TRYMEX | triamcinolone acetonide | CREAM;TOPICAL | 088197-001 | Mar 25, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |